Zentiva’s attempt to alter case schedule rejected in UPC patent dispute with Sanofi
MLex Summary: Zentiva’s bid to change the written procedure timeline and limit Sanofi’s submissions was rejected by the Unified Patent Court in a dispute over European patent 2,493,466 relating to a...To view the full article, register now.
Already a subscriber? Click here to view full article